Patents Assigned to SIRTRIS PHARMACEUTICAS, INC.
  • RESVERATROL FORMULATIONS
    Publication number: 20110009496
    Abstract: Resveratrol can be used to treat or inhibit the onset of many diseases that are related to the aging process, but large doses are required. The present invention provides concentrated liquid formulations of resveratrol, typically having a resveratrol concentration of at least 10% by weight. These formulations improve patient compliance because the patient need not consume such a large volume of a resveratrol formulation.
    Type: Application
    Filed: January 7, 2009
    Publication date: January 13, 2011
    Applicant: SIRTRIS PHARMACEUTICAS, INC.
    Inventors: Walter Joseph Lunsmann, Peter Elliott, Philip Lambert